Successful Interventions for Gram‐Negative Resistance to Extended‐Spectrum β‐Lactam Antibiotics

Pharmacotherapy - Tập 19 Số 8P2 - 1999
Louis B. Rice1
1Department of Medicine and Research Service, Veterans Affairs Medical Center, and the Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio.

Tóm tắt

Antibiotic resistance among nosocomial pathogens in this country's hospitals adds significantly to patient morbidity and mortality and the cost of health care. Optimism for identifying antimicrobial agents that would “solve the problem” of resistance has been replaced by a much more guarded and realistic view of the battle between humans and pathogenic microorganisms. Efforts now are more appropriately directed toward limiting, rather than completely eliminating, resistance, generally by either infection control or antibiotic control measures, and sometime combinations of the two. Methicillin‐oxacillin resistance in Staphylococcus aureus (MRSA) results from the expression of an acquired penicillin‐binding protein (PBP 2a) that is not transferable in vitro. In most hospitals, even those with high percentages of MRSA, relatively few resistant clones are identified, suggesting transmission of individual strains throughout the hospital population. Because person‐to‐person spread is so important in transmission of MRSA, strategies aimed at preventing transmission of the resistant strains are remarkably effective when strictly enforced. Ceftazidime resistance in Enterobacteriaceae results from point mutations within genes that encode widely prevalent and often transferable plasmid‐mediated enzymes. In addition, mutations of these genes that allow hydrolysis of cephalosporins usually result in decreased activity against other drugs, including the penicillins and β‐lactamase inhibitors. Effective measures to control ceftazidime‐resistant Enterobacteriaceae have as their cornerstone limiting administration of antibiotics that select for the emergence and spread of these mutations, especially ceftazidime. The importance of infection‐control techniques in limiting the prevalence of ceftazidime‐resistant Enterobacteriaceae is less well established. Methods that are informed by a detailed understanding of the molecular mechanisms of resistance and resistance spread offer the best hope for limiting dissemination of antibiotic‐resistant bacteria in a cost‐effective manner.

Từ khóa


Tài liệu tham khảo

10.1086/513766

10.1128/AAC.36.9.2046

10.1128/CMR.10.4.781

10.1128/MMBR.51.1.88-134.1987

10.7326/0003-4819-124-6-199603150-00001

10.1086/646291

Boyce JM, 1994, Outbreak of multidrug‐resistant Enterococcus faecium with transferable van B class vancomycin resistance, J Clin Microbiol, 32, 1148, 10.1128/jcm.32.5.1148-1153.1994

10.2307/30141115

10.7326/0003-4819-117-2-112

10.7326/0003-4819-123-4-199508150-00002

10.7326/0003-4819-125-6-199609150-00004

10.1007/BF01963632

10.1128/AAC.42.8.1871

Carias LL, 1998, Genetic linkage and co‐transfer of a novel, van B‐encoding transposon (Tn5382) and a low‐affinity penicillin‐binding protein 5 gene in a clinical vancomycin‐resistant Enterococcus faecium isolate, J Bacteriol, 180, 4426

Medeiros AA, 1986, Beta‐lactam antibiotics for clinical use, 49

10.1093/clinids/8.5.713

10.1128/AAC.35.9.1697

10.1128/AAC.37.12.2760

10.1128/JCM.34.4.908-911.1996

10.1128/AAC.35.6.1243

10.1093/clinids/23.1.118

10.1128/AAC.41.3.647

Christensen H., 1990, β‐Lactamases as fully efficient enzymes, Biochem J, 266, 853

10.1007/BF01645566

10.1128/AAC.34.5.858

10.1128/AAC.34.11.2193

10.7326/0003-4819-119-5-199309010-00001

Peña C., 1998, Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended‐spectrum β‐lactamases, Antimicrob Agents Chemother, 42, 53, 10.1128/AAC.42.1.53

10.1093/clinids/22.3.430

10.1016/S0195-6701(97)90163-8

10.1093/infdis/174.3.529

10.1016/S0140-6736(87)90891-9

10.1093/jac/37.1.203

10.1093/infdis/173.1.151

10.1093/infdis/159.5.1005

Ardanuy C., 1998, Outer membrane profiles of clonally related Klebsiella pneumoniae isolates from clinical samples and activities of cephalosporins and carbapenems, Antimicrob Agents Chemother, 42, 1636, 10.1128/AAC.42.7.1636

10.1128/AAC.39.6.1211

10.1128/AAC.38.11.2663

French GL, 1996, Hospital outbreak of Klebsiella pneumoniae resistant to broad‐spectrum cephalosporins and β‐lactam‐β‐lactamase inhibitor combinations by hyperproduction of SHV‐5 β‐lactamase, J Clin Microbiol, 34, 358, 10.1128/jcm.34.2.358-363.1996

10.1111/j.1574-6968.1992.tb05240.x

10.1016/S0140-6736(94)90694-7

10.1086/514643

10.1086/647654

10.1097/00003246-199703000-00026

Thông tin
Thông tin xuất bản

Pharmacotherapy

Tập 19 Số 8P2

Thông tin tác giả